I am pleased to announce that Dr. Parameswaran Hari will be the feature panelist on a Cure Panel broadcast on September 25, 2012 @ 4:30pm EST. The focus of the discussion will be multiple myeloma disease progression, and the treatments for relapsed, refractory, and high risk multiple myeloma. You can sign up for this presentation at the following link: http://trialx.com/curetalk/panels/myeloma-cure-panel-on-25th-september-2012-430-pm-hurry-and-register/
Multiple myeloma becomes more and more resistant with continued treatment, and high risk disease is by definition difficult to find effective treatment. Therefore, relapsed, refractory and high risk disease are the elements that most impact your long term life expectancy. They are also often the signal that your disease has returned, and this is one thing that all myeloma patients and caregivers fear!
Dr. Hari is the Section Head and Clinical Director at the Medical College of Wisconsin. He has the best 2 and 3 year myeloma survival rates yet presented on www.myelomasurvival.com. You are 7.2 times more likely to survive for 3 years in his care than in the care of the average facility that reports their data to the National Cancer Institutes national SEER registry. He was voted to the nation's Best Doctors in 2011-2012, and is the President of the national organization CIBMTR(Center for International Blood and Marrow Transplant Research)Transplant Hospitals. His knowledge and incites will be invaluable to the myeloma patient community. Unfortunately, there will be only 50 callers allowed into the broadcast. So please hurry to be included live on the panel and ask Dr. Hari your multiple myeloma questions.